COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 (ES24)
ES24 . Key messages The content of this evidence review was up-to-date
Search results
47 results
-
-
COVID-19 rapid evidence summary: Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES25)
ES25 . Key messages The content of this evidence review was up-to-date on 20 April 2020. See summaries of product characteristics
-
COVID 19 rapid evidence summary: Anakinra for COVID-19 associated secondary haemophagocytic lymphohistiocytosis (ES26)
ES26 . Key messages The content of this evidence review was up-to-date on 13 May 2020. See summaries of product characteristics
-
COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 (ES23)
ES23 . Key messages The content of this evidence review was up-to-date
-
COVID-19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)
ES27 . Key messages The content of this evidence review was up-to-date on 4 June 2020. See summaries of product characteristics
-
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
ES33 Product overview The content of this evidence summary was up to date in January 2021. See summaries of product characteristics
-
myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
NICE has developed a medtech innovation briefing (MIB) on myCOPD for self-management of chronic obstructive pulmonary disease
-
KardiaMobile for the ambulatory detection of atrial fibrillation (MIB232)
NICE has developed a medtech innovation briefing (MIB) on KardiaMobile for the ambulatory detection of atrial fibrillation
-
Dexcom G6 for real-time continuous glucose monitoring (MIB233)
NICE has developed a medtech innovation briefing (MIB) on Dexcom G6 for real-time continuous glucose monitoring
-
ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream infections (MIB234)
NICE has developed a medtech innovation briefing (MIB) on ClearGuard HD Antimicrobial Barrier Cap for preventing haemodialysis catheter-related bloodstream
-
NPi-200 for pupillary light reflex in critical care patients (MIB235)
NICE has developed a medtech innovation briefing on NPi-200 for pupillary light reflex in critical care patients
-
Magseed for locating impalpable breast cancer lesions (MIB236)
NICE has developed a medtech innovation briefing on Magseed for locating impalpable breast cancer lesions
-
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
NICE has developed a medtech innovation briefing (MIB) on QuickChange Incontinence Wrap for urinary incontinence in men
-
Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain (MIB238)
NICE has developed a medtech innovation briefing (MIB) on Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
-
ReStore Soft Exo-Suit for gait rehabilitation (MIB239)
NICE has developed a medtech innovation briefing (MIB) on ReStore Soft Exo-Suit for gait rehabilitation
-
Cytosponge for detecting abnormal cells in the oesophagus (MIB240)
NICE has developed a medtech innovation briefing (MIB) on Cytosponge for detecting abnormal cells in the oesophagus
-
AnaConDa-S for sedation with volatile anaesthetics in intensive care (MIB229)
NICE has developed a medtech innovation briefing (MIB) on AnaConDa-S for sedation with volatile anaesthetics in intensive care
-
3C Patch System for treating diabetic foot ulcers (MIB230)
NICE has developed a medtech innovation briefing (MIB) on 3C Patch System for treating diabetic foot ulcers
-
Tegaderm CHG securement dressing for vascular access sites (MIB231)
NICE has developed a medtech innovation briefing (MIB) on Tegaderm CHG securement dressing for vascular access sites
-
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MIB210)
NICE has developed a medtech innovation briefing (MIB) on TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation
-
Archimedes for biopsy of suspected lung cancer (MIB211)
NICE has developed a medtech innovation briefing (MIB) on Archimedes for biopsy of suspected lung cancer
-
MolecuLight i:X for wound imaging (MIB212)
NICE has developed a medtech innovation briefing (MIB) on MolecuLight i:X for wound imaging
-
Lifelight First for monitoring vital signs (MIB213)
NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs
-
Space from Depression for treating adults with depression (MIB215)
NICE has developed an Improving Access to Psychological Therapies (IAPT) report on Space from Depression for treating adults with depression
-
FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216)
NICE has developed a medtech innovation briefing (MIB) on FibroScan for assessing liver fibrosis and cirrhosis in primary care
-
Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)
NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19
-
Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome (MIB223)
NICE has developed a medtech innovation briefing (MIB) on Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome
-
FebriDx for C-reactive protein and myxovirus resistance protein A testing (MIB224)
NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing
-
Helge for detecting haemolysis (MIB225)
NICE has developed a medtech innovation briefing (MIB) on Helge for detecting haemolysis
-
Synergo for non-muscle-invasive bladder cancer (MIB226)
NICE has developed a medtech innovation briefing (MIB) on Synergo for non-muscle-invasive bladder cancer
-
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)
NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes
-
Novii Wireless Patch System for maternal and fetal monitoring (MIB228)
NICE has developed a medtech innovation briefing (MIB) on Novii Wireless Patch System for maternal and fetal monitoring
-
Actim Pancreatitis for diagnosing acute pancreatitis (MIB218)
NICE has developed a medtech innovation briefing (MIB) on Actim Pancreatitis for diagnosing acute pancreatitis
-
CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic (MIB219)
NICE has developed a medtech innovation briefing (MIB) on CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic
-
Prontosan for acute and chronic wounds (MIB220)
NICE has developed a medtech innovation briefing (MIB) on Prontosan for acute and chronic wounds
-
Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)
NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio
-
pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms (MIB222)
NICE has developed a medtech innovation briefing (MIB) on pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms
-
Artificial intelligence for analysing CT brain scans (MIB207)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans
-
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds (MIB208)
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wound
-
EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules (MIB209)
NICE has developed a medtech innovation briefing (MIB) on EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules
-
Plus Sutures for preventing surgical site infection (MIB204)
NICE has developed a medtech innovation briefing (MIB) on Plus Sutures for preventing surgical site infection
-
National Early Warning Score systems that alert to deteriorating adult patients in hospital (MIB205)
NICE has developed a medtech innovation briefing (MIB) on National Early Warning Score systems that alert to deteriorating adult patients in hospital
-
Cor-Knot for tying suture knots in valve surgery (MIB206)
NICE has developed a medtech innovation briefing (MIB) on Cor-Knot for tying suture knots in valve surgery
-
Artificial intelligence in mammography (MIB242)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography
-
Optilume for anterior urethral strictures (MIB241)
NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures
-
Artificial intelligence for analysing chest CT images (MIB243)
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing chest CT images
-
COVID-19 rapid evidence summary: vitamin D for COVID-19 (ES28)
This evidence summary has been updated and replaced by the COVID-19 rapid guideline on vitamin D (NG187).